Price$109.31+2.05 (+1.91%)
01:30 PM07:45 PM
News · 26 weeks53+200%
2026-04-192026-10-11
Mix2290d
- Insider9(41%)
- SEC Filings6(27%)
- Other4(18%)
- Earnings2(9%)
- Analyst1(5%)
Latest news
25 items- PRiRhythm Holdings to Report Third Quarter 2026 Financial Results on November 5, 2026SAN FRANCISCO, Oct. 15, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced that it will release financial results for the third quarter 2026 after the close of trading on Thursday, November 5, 2026. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may access a live and archived webcast of the conference call on the "Quarterly Results" section of the company’s investor website at investors.irhythmtech.com. About iRhythm Holdings, Inc. iRhythm is a leading digita
- SECAmendment: SEC Form SCHEDULE 13G/A filed by iRhythm Holdings Inc.SCHEDULE 13G/A - iRhythm Holdings, Inc. (0001388658) (Subject)
- SECiRhythm Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - iRhythm Holdings, Inc. (0001388658) (Filer)
- PRiRhythm Completes Acquisition of VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home CareCombination broadens iRhythm’s cardiac monitoring portfolio, advances its multi-vitals strategy and expands iRhythm’s addressable market across the continuum of care.iRhythm’s commercial scale, health system relationships, market access expertise, and integrated clinical service capabilities are expected to accelerate VitalConnect's growth and expand customer access.Transaction is expected to enhance iRhythm's revenue growth rate beginning in 2027 while preserving iRhythm’s previously communicated 15% adjusted EBITDA margin target for 2027. SAN FRANCISCO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC) today announced that it completed the previously announced acqui
- PRiRhythm Provides Update on Cybersecurity Incident Previously Disclosed in June 2026SAN FRANCISCO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC) today provided an update regarding the cybersecurity incident previously disclosed in June 2026. Following completion of the forensic investigation and subsequent review to determine the nature of the impacted data, the company has begun notifying impacted individuals. As previously disclosed, on or around June 8, 2026, iRhythm detected unauthorized access in certain third-party-hosted business applications. Upon detecting the unauthorized access, iRhythm promptly implemented its incident response plan. As part of the investigation, iRhythm has been working very closely with external cybersecurity profes
- SECiRhythm Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure8-K - iRhythm Holdings, Inc. (0001388658) (Filer)
- INSIDERChief Financial Officer Wilson Daniel G. sold $94,175 worth of shares (773 units at $121.83), decreasing direct ownership by 2% to 34,887 units (SEC Form 4) (tax withholding)4 - iRhythm Holdings, Inc. (0001388658) (Issuer)
- PRiRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare ConferenceSAN FRANCISCO, Aug. 26, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced that it will participate in the upcoming Wells Fargo 21st Annual Healthcare Conference. iRhythm’s management is scheduled to present on Wednesday, September 9, 2026, at 8:45 a.m. ET. Interested parties may access a live and archived webcast of the fireside chat on the "Events & Presentations" section of the company’s investor website at investors.irhythmtech.com. About iRhythm Holdings, Inc. iRhythm is a leading digital health care company that creates trusted solutions
- SECiRhythm Holdings Inc. filed SEC Form 8-K: Leadership Update8-K - iRhythm Holdings, Inc. (0001388658) (Filer)
- INSIDERPresident and CEO Blackford Quentin S. was granted 48,534 shares and sold $3,348,012 worth of shares (26,859 units at $124.65), increasing direct ownership by 11% to 226,008 units (SEC Form 4) (for withholding tax)4 - iRhythm Holdings, Inc. (0001388658) (Issuer)
- INSIDERCBO and CLO Murphy Patrick Michael was granted 13,589 shares and sold $884,156 worth of shares (7,093 units at $124.65), increasing direct ownership by 10% to 69,699 units (SEC Form 4) to satisfy withholding tax4 - iRhythm Holdings, Inc. (0001388658) (Issuer)
- INSIDEREVP, Chief Risk Officer Shrishrimal Sumi was granted 9,706 shares and sold $669,641 worth of shares (5,372 units at $124.65), increasing direct ownership by 11% to 44,621 units (SEC Form 4) (withholding tax)4 - iRhythm Holdings, Inc. (0001388658) (Issuer)
- INSIDERCHIEF COMM & PRODUCT OFFICER Patterson Chad was granted 13,589 shares and sold $884,170 worth of shares (7,093 units at $124.65), increasing direct ownership by 12% to 62,125 units (SEC Form 4) (for withholding tax)4 - iRhythm Holdings, Inc. (0001388658) (Issuer)
- INSIDERCHIEF MED/SCI OFCR EVP ADVTECH Turakhia Minang sold $884,151 worth of shares (7,093 units at $124.65) and was granted 13,589 shares, increasing direct ownership by 12% to 60,116 units (SEC Form 4) to satisfy tax liability4 - iRhythm Holdings, Inc. (0001388658) (Issuer)
- SECSEC Form 10-Q filed by iRhythm Holdings Inc.10-Q - iRhythm Holdings, Inc. (0001388658) (Filer)
- SECiRhythm Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - iRhythm Holdings, Inc. (0001388658) (Filer)
- SECiRhythm Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - iRhythm Holdings, Inc. (0001388658) (Filer)
- PRiRhythm to Acquire VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home CareUpon closing, combination immediately broadens iRhythm's ambulatory cardiac monitoring portfolio, including in the large and growing mobile cardiac telemetry category, and adds continuous multi-vitals monitoring capabilitiesiRhythm’s commercial scale, health system relationships, market access expertise, and integrated clinical service capabilities are expected to accelerate VitalConnect's growth and expand customer accessTransaction is expected to enhance iRhythm's revenue growth rate beginning in 2027 while preserving iRhythm’s previously communicated 15% adjusted EBITDA margin target for 2027iRhythm management to discuss the transaction on iRhythm’s second quarter financial results confer
- INSIDEREVP Strategic Business Ops Smith Mervin sold $75,349 worth of shares (617 units at $122.12), decreasing direct ownership by 3% to 22,410 units (SEC Form 4) (withholding obligation)4 - iRhythm Holdings, Inc. (0001388658) (Issuer)
- INSIDEREVP, CHIEF PEOPLE OFFICER Rodda Julianne sold $257,919 worth of shares (2,112 units at $122.12), decreasing direct ownership by 10% to 18,201 units (SEC Form 4) (tax withholding)4 - iRhythm Holdings, Inc. (0001388658) (Issuer)
- INSIDERCHIEF COMM & PRODUCT OFFICER Patterson Chad sold $331,192 worth of shares (2,712 units at $122.12), decreasing direct ownership by 5% to 55,629 units (SEC Form 4) to cover taxes4 - iRhythm Holdings, Inc. (0001388658) (Issuer)
- ANALYSTStephens initiated coverage on iRhythm with a new price targetStephens initiated coverage of iRhythm with a rating of Overweight and set a new price target of $160.00
- PRiRhythm Holdings to Report Second Quarter 2026 Financial Results on August 6, 2026SAN FRANCISCO, July 16, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced that it will release financial results for the second quarter 2026 after the close of trading on Thursday, August 6, 2026. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may access a live and archived webcast of the conference call on the "Quarterly Results" section of the company’s investor website at investors.irhythmtech.com. About iRhythm Holdings, Inc. iRhythm is a leading digital
- INSIDEREVP, Strategy & Corp Devt Freeman Sean Clinton sold $114,484 worth of shares (918 units at $124.71), decreasing direct ownership by 6% to 13,641 units (SEC Form 4) to satisfy withholding obligation4 - iRhythm Holdings, Inc. (0001388658) (Issuer)
- INSIDERCHIEF MED/SCI OFCR EVP ADVTECH Turakhia Minang sold $177,462 worth of shares (1,423 units at $124.71), decreasing direct ownership by 3% to 53,620 units (SEC Form 4) to satisfy withholding tax4 - iRhythm Holdings, Inc. (0001388658) (Issuer)
IRTC FAQ
7 questionsWhat does iRhythm Holdings Inc. do?
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration...Where does IRTC stock trade?
iRhythm Holdings Inc. (IRTC) is listed on NASDAQ.What sector and industry is IRTC in?
iRhythm Holdings Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did iRhythm Holdings Inc. go public?
iRhythm Holdings Inc. (IRTC) completed its IPO in 2016.What are analysts saying about IRTC?
iRhythm Holdings Inc. has had 8 recent analyst actions on file. The most recent action was from Stephens: Overweight on 2026-07-23.What companies are similar to IRTC?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare IRTC side-by-side with any of them on Quantisnow.How can I track IRTC on Quantisnow?
Quantisnow aggregates iRhythm Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow IRTC to receive live email and push alerts on every new disclosure.